Florian Märkl

8PUBLICATIONS
74CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 24, 2026
FLT3-directed BiTE molecules vs CAR T cells in AML: costimulatory signals mitigate T-cell exhaustion.

Lisa Rohrbacher, Daniel Nixdorf, Helena Stadler

|Dec 01, 2025
FLT3-directed BiTE molecules vs CAR T cells in AML: costimulatory signals mitigate T-cell exhaustion.

Lisa Rohrbacher, Daniel Nixdorf, Helena Stadler

|Apr 03, 2025
Dissection of single-cell landscapes for the development of chimeric antigen receptor T cells in Hodgkin lymphoma.

Adrian Gottschlich, Ruth Grünmeier, Gordon Victor Hoffmann

|Feb 02, 2024
Mutation-specific CAR T cells as precision therapy for IGLV3-21R110 expressing high-risk chronic lymphocytic leukemia.

Florian Märkl, Christoph Schultheiß, Murtaza Ali

|Jul 03, 2023
Rational design of PD-1-CD28 immunostimulatory fusion proteins for CAR T cell therapy.

Theo Lorenzini, Bruno L Cadilha, Hannah Obeck

|May 19, 2023
Bispecific antibodies redirect synthetic agonistic receptor modified T cells against melanoma.

Florian Märkl, Mohamed-Reda Benmebarek, Julius Keyl

Pageof 2

Frequent Collaborators

8 joint publications

Sebastian Kobold

5 joint publications

Theo Lorenzini

4 joint publications

Ruth Grünmeier

4 joint publications

Matthias Seifert